Insufficient expression of components of the TGF-beta1 autocrine growth suppressive circuit in human ovarian cancer cell lines
Zeinoun, Z.; Teugels, E.; Debleser, P.; Geerts, A.; Neyns, B.; De Greve, J.
Proceedings of the American Association for Cancer Research 39: 205
1998
ISSN/ISBN: 0569-2261 Accession: 031966270
PDF emailed within 1 workday: $29.90
Related References
Zeinoun, Z.; Teugels, E.; De Bleser, P.J.; Neyns, B.; Geerts, A.; De Greve, J. 1999: Insufficient TGF-beta 1 production inactivates the autocrine growth suppressive circuit in human ovarian cancer cell lines Anticancer Research 19(1a): 413-420Norgaard, P.; Damstrup, L.; Spang Thomsen, M.; Poulsen, H.S. 1993: Expression of transforming growth factor-beta receptors and growth suppressive effect of transforming growth factor-beta in human small cell lung cancer cell lines Proceedings of the American Association for Cancer Research 34: 52
Xiong, S.; Chen, Y.; Wu, A. 1996: Autocrine transforming growth factor-beta stimulates human ovarian cancer cell growth in vitro and in vivo Zhonghua Fu Chan Ke Za Zhi 31(1): 22-24
Coffey, R.J.; Goustin, A.S.; Soderquist, A.M.; Shipley, G.D.; Wolfshohl, J.; Carpenter, G.; Moses, H.L. 1987: Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model Cancer Research 47(17): 4590-4594
Damstrup, L.; Rygaard, K.; Spang-Thomsen, M.; Skovgaard Poulsen, H. 1993: Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and TGF beta 3 in human small cell lung cancer cell lines British Journal of Cancer 67(5): 1015-1021
Angelsen, A.; Sandvik, A.K.; Syversen, U.; Stridsberg, M.; Waldum, H.L. 1998: NGF-beta, NE-cells and prostatic cancer cell lines. A study of neuroendocrine expression in the human prostatic cancer cell lines DU-145, PC-3, LNCaP, and TSU-pr1 following stimulation of the nerve growth factor-beta Scandinavian Journal of Urology and Nephrology 32(1): 7-13
Woloszynska-Read, A.; James, S.R.; Song, C.; Jin, B.; Odunsi, K.; Karpf, A.R. 2010: BORIS/CTCFL expression is insufficient for cancer-germline antigen gene expression and DNA hypomethylation in ovarian cell lines Cancer Immunity 10: 6
Okumura, K.; Konishi, A.; Tanaka, M.; Hagino, T.; Nagayasu, H.; Katoh, M.; Kawano, H.; Shibata, T.; Kanazawa, M. 1996: Autocrine action of transforming growth factor-.BETA.1 (TGF-.BETA.1) in the invasiveness of human oral squamous cell carcinoma cell lines Japanese Journal of Oral-Maxillofacial Surgery 42(10): 962-968
Angelsen, A.; Sandvik, A.K.; Syversen, U.; Stridsberg, M.; Waldum, H.L. 1998: NGF-beta, NE-cells and prostatic cell lines: A study of neuroendocrine expression in the human prostatic cancer cell lines DU-145, PC-3, LNCaP, and TSU-pr1 following stimulation of the nerve growth factor-beta Scandinavian Journal of Urology and Nephrology 32(1): 7-13
Di Simone, N.; Crowley, W.F.; Wang, Q.F.; Sluss, P.M.; Schneyer, A.L. 1996: Characterization of inhibin/activin subunit, follistatin, and activin type Ii receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation Endocrinology 137(2): 486-494
Bartlett, J.M.S.; Rabiasz, G.J.; Scott, W.N.; Langdon, S.P.; Smyth, J.F.; Miller, W.R. 1992: Growth regulation of human ovarian carcinoma cell lines may involve multiple growth factor mediated autocrine pathways Proceedings of the American Association for Cancer Research 33: 271
Harsh, G.R.; Keating, M.T.; Escobedo, J.A.; Williams, L.T. 1990: Platelet derived growth factor (PDGF) autocrine components in human tumor cell lines Journal of Neuro-Oncology 8(1): 1-12
Nørgaard, P.; Damstrup, L.; Rygaard, K.; Spang-Thomsen, M.; Skovgaard Poulsen, H. 1994: Growth suppression by transforming growth factor beta 1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor British Journal of Cancer 69(5): 802-808
Wolfshohl, J.; Coffey, R.J.; Moses, H.L. 1987: Tgf alpha and tgf beta expression in human colon carcinoma cell lines implications for an autocrine model Journal of Cellular Biochemistry Suppl (11 Part A): 49
Berchuck, A.; Rodriguez, G.; Olt, G.; Arrick, B.; Clarke Pearson, D.L.; Bast, R.C.Jr 1991: Regulation of growth of normal ovarian epithelium and ovarian cancer cell lines by transforming growth factor beta Gynecologic Oncology 40(2): 182
Berchuck, A.; Rodriguez, G.; Olt, G.; Whitaker, R.; Boente, M.P.; Arrick, B.A.; Clarke-Pearson, D.L.; Bast, R.C. 1992: Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-beta American Journal of Obstetrics and Gynecology 166(2): 676-684
Fox, F.E.; Douglas, R.S.; Cherian, S.; Nowell, P.C. 1992: Inhibition of human t cell proliferation by transforming growth factor beta may have both autocrine and paracrine components FASEB Journal 6(4): A1139
Nicoletti, M.I.; Valoti, G.; Giannakakou, P.; Zhan, Z.; Kim, J.H.; Lucchini, V.; Landoni, F.; Mayo, J.G.; Giavazzi, R.; Fojo, T. 2001: Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-Anticancer Drug Screen: correlation with sensitivity to microtubule active agents Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(9): 2912-2922
Chen, Y.; Wang, X.; Duan, C.; Chen, J.; Su, M.; Jin, Y.; Deng, Y.; Wang, D.; Chen, C.; Zhou, L.; Cheng, J.; Wang, W.; Xi, Q. 2016: Loss of TAB3 expression by shRNA exhibits suppressive bioactivity and increased chemical sensitivity of ovarian cancer cell lines via the NF-κB pathway Cell Proliferation 49(6): 657-668
Olt, G.; Berchuck, A.; Cram, G.; Boyer, C.M.; Bast, R.C.Jr 1990: Growth regulation of ovarian cancer cell lines by transforming growth factor beta tgf beta Proceedings of the American Association for Cancer Research 31: 53